Latest Breaking News On - Typei allergic reactions - Page 1 : comparemela.com

ARS Pharmaceuticals Submits Response to FDA Complete Response Letter for neffy® (Epinephrine Nasal Spray)

ARS Pharmaceuticals Submits Response to FDA Complete Response Letter for neffy® (Epinephrine Nasal Spray)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesRichard lowenthalLaura oneillJustin chakmaAdvisory committeeExchange commissionPharmaceuticals incPharmaceuticals submits responseDrug administrationSubmits responseResponse letterEpinephrine nasal sprayNew drug applicationComplete response letterTypei allergic reactionsPrivate securities litigation reform act

ARS Pharmaceuticals Submits Response to FDA Complete Response Letter for neffy® (Epinephrine

Response addresses all additional requests in FDA CRL, including positive data from a repeat dose PK/PD study of neffy under nasal allergen challenge (NAC) conditions, and updated testing that detected

United statesRichard lowenthalLaura oneillJustin chakmaPharmaceuticals incAdvisory committeeDrug administrationExchange commissionNew drug applicationComplete response letterTypei allergic reactionsPrivate securities litigation reform actAnnual report

ARS Pharma Announces Favorable Topline Results from Repeat Dosing Study of neffy® (Epinephrine Nasal Spray) Under Nasal Allergen Challenge Conditions, Readies Data for Response to FDA s Complete Response Letter

ARS Pharma Announces Favorable Topline Results from Repeat Dosing Study of neffy® (Epinephrine Nasal Spray) Under Nasal Allergen Challenge Conditions, Readies Data for Response to FDA s Complete Response Letter
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLaura oneillRichard lowenthalJustin chakmaThomasb casaleEuropean medicines agencyAdvisory committeeUniversity of south floridaExchange commission onDrug administrationTranslational research in allergy immunologyCommittee for medicinal products human usePharmaceuticals incAnnounces favorable topline resultsRepeat dosing studyEpinephrine nasal spray

ARS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updates

ARS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRichard lowenthalJustin chakmaSherry korczynskiExchange commissionAmerican college of allergyPharmaceuticals incEuropean medicines agencyAdvisory committeeNew drug applicationClinical immunologyComplete response letterBusiness updatesTypei allergic reactionsPrivate securities litigation reform actQuarterly report

ARS Pharmaceuticals Announces Scheduling of a Type A Meeting with the U S FDA for neffy® (epinephrine nasal spray)

SAN DIEGO, Oct. 06, 2023 ARS Pharmaceuticals, Inc. , a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients from severe allergic reactions.

United statesJustin chakmaRichard lowenthalLaura oneillAllergy drugs advisory committeeDrug administrationExchange commission onAdvisory committee the pulmonaryPharmaceuticals incComplete response letterPulmonary allergy drugs advisory committeeTypei allergic reactionsPrivate securities litigation reform actQuarterly reportExchange commissionInvestor contact